This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Sorbonne Université. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 266 Years Active: 2021
Title: Michael Housset: Innovator in Inflammation Treatment
Introduction
Michael Housset is a notable inventor based in Québec, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of inflammation. His innovative work focuses on agents that activate CD47, which play a crucial role in addressing non-resolving low-grade inflammation.
Latest Patents
Housset holds a patent for "Agents that activate CD47 and their use in the treatment of inflammation." This patent discloses agents that activate CD47 and their application in treating inflammation, especially in cases characterized by chronic macrophage infiltration, such as age-related macular degeneration. The patent also includes pharmaceutical compositions, medicaments, and kits that incorporate these agents. He has 1 patent to his name.
Career Highlights
Throughout his career, Michael Housset has worked with prestigious institutions, including Sorbonne Université and the Centre National de la Recherche Scientifique. His research has significantly advanced the understanding of inflammation and its treatment.
Collaborations
Housset has collaborated with notable colleagues, including Florian Sennlaub and Xavier Guillonneau. Their combined expertise has contributed to the development of innovative solutions in the medical field.
Conclusion
Michael Housset's work in activating CD47 represents a significant advancement in the treatment of inflammation. His contributions to medical research and innovation continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile